Adjusting The Dose of Zepbound for Personalized Weight Loss Once youve initiated treatment with Zepbound (tirzepatide) at the preliminary dose of 2.5 mg, your healthcare provider will likely recommend adjusting the dosage over time to best suit your weight loss process

Resources: GLP-1 Agonists Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes Safety of Semaglutide Once-Weekly Semaglutide in Adults with Overweight or Obesity Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity Medication-Induced Gastroparesis: A Case Report Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASSCVOT design and baseline characteristics Tirzepatide for the treatment of obstructive sleep apnea: Rationale, design, and sample baseline characteristics of the SURMOUNT -OSA phase 3 trial Tirzepatide prevents neurodegeneration through multiple molecular pathways TripleHormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial Biology of Incretins: GLP-1 and GIP GIP and GLP1, the two incretin hormones: Similarities and differences GLP-1, GIP and glucagon receptor poly-agonists: A new era in obesity pharmacotherapy

However, in some cases, your healthcare provider may recommend this off-label combination therapy
Nearly a tenth of people will meet the clinical benchmarks of an eating disorder at some point in their lives
For most people, the practical approach involves working with a healthcare provider to establish a baseline through blood work, then adjusting session frequency based on symptom improvement and lab results
Higher protein intake is necessary during weight loss to support muscle repair and preservation when calories are reduced